martindale.com
Legal Library
|
FTC Challenges Consummated Drug Acquisition; Two Commissioners Suggest Sale to Firm Unconstrained by Reputation to Keep Prices Low Could Violate Section 7 by Christopher J. Kelly
Mayer Brown LLP - Washington Office
John Roberti
Mayer Brown LLP - Washington Office
Richard M. Steuer
Mayer Brown LLP - New York Office
Caroline E. Brown
Mayer Brown LLP - Washington Office
|
|
January 26, 2009
Previously published on December 23, 2008
Signs of aggressive new merger enforcement positions are evident in the Federal Trade Commission's (FTC's) challenge of the acquisition of a drug to treat a heart condition in premature babies.
|
The views expressed in this document are solely the views of the author and not Martindale-Hubbell. This document is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
| | View More Library Documents By... | | | | |
| | | | Mayer Brown LLP Overview |
Practice Area Resource Centers
|
|